EVennCorona: Annotating Protein Corona of Extracellular Vesicles by Venn Diagram Authors: Somchai Chutipongtanate Published: 2026 ABSTRACT ABSTRACTExtracellular vesicles (EVs) circulating in human blood are coated by adsorbed plasma proteins, termed the EV protein corona. The corona is an intrinsic property of EVs in vivo, forming through selective adsorption of tissue microenvironment secretome components and plasma proteins, and modulates key EV biological functions including cellular targeting, biodistribution, immunomodulation and tissue regeneration. These properties have emerging implications for therapeutic EV bioengineering. However, the corona also confounds plasma EV biomarker discovery by obscuring intrinsic vesicular proteins. Despite its importance, systematic and accessible annotation of EV‐associated protein corona is lacking. EVennCorona is a web‐based resource for annotating plasma‐derived EV proteins using Venn diagram‐based comparisons with curated protein corona reference datasets. The database integrates experimental validated comparative proteomics of EVs with and without corona across diverse EV populations. EVennCorona facilitates prioritisation of intrinsic EV proteins for plasma EV biomarker discovery and supports investigation of EV corona biology. The resource is available at https://schuti.github.io/EVennCorona. Main Text Despite decades of methodological advances, effective removals of soluble proteins and lipoproteins from extracellular vesicle (EV) isolates remain challenging, particularly in protein‐rich biofluids such as blood plasma (Buzas 2022). It is now well established that EVs acquire a corona, a dynamic layer of surface‐adsorbed biomolecules analogous to synthetic nanoparticles, upon exposure to complex biofluids (Buzas 2022; Palviainen et al. 2020; Tóth et al. 2021; Wolf et al. 2022; Dietz et al. 2023). Beyond plasma‐derived proteins, secretome components released from EV‐producing cells, including lipids, DNA and RNA, also contribute to the formation of the functional corona (Yerneni et al. 2022), collectively constituting an extended surface cargo of EVs (Buzas 2022; Palviainen et al. 2020; Wolf et al. 2022; Ripoll et al. 2026). The composition of the EV corona varies across EV populations and extracellular microenvironments (Tóth et al. 2021; Wolf et al. 2022; Dietz et al. 2023; Singh et al. 2023; Musicò et al. 2024; Armengol‐Badia et al. 2024), and play crucial roles in cellular targeting, biodistribution and uptake (Dietz et al. 2023; Musicò et al. 2023; Liam‐Or et al. 2024). Moreover, the corona modulates EV biological functions, including angiogenesis, biomineralisation, immunomodulation and tissue regeneration (Wolf et al. 2022; Cominal et al. 2024; Lee et al. 2025). Protein corona formation is therefore an intrinsic property of EVs in vivo, as protein adsorption is inevitable in the protein‐rich environments that EVs naturally traverse. The absorbed corona proteins may form through two sequential processes; surface adsorption of secretome components from the tissue microenvironment upon EV biogenesis, followed by a secondary coating of plasma proteins upon entry into systemic circulation. The former may convey microenvironment‐specific functionalities, while the latter may protect intrinsic EV cargo from proteolytic degradation, with both layers potentially contributing surface ligands that modulate EV biodistribution and cellular targeting. As such, the EV corona has emerged as a frontier of EV biology, with implications for understanding complex pathophysiological roles and advancing EV‐based nanotherapeutics. Nonetheless, this functional layer presents a substantial obstacle for EV biomarker discovery. Biomarker studies of plasma‐derived EVs are confounded by the abundance of plasma proteins, such as albumin, immunoglobulins, apolipoproteins, complement components and fibrinogens, that dominate the EV corona. This interference is two‐fold. First, corona proteins constitute a substantial proportion of the protein (and peptide) mass in the plasma‐derived EV preparations and compete with intrinsic EV proteins during mass spectrometric‐based proteomic analyses, irrespective of data‐dependent or data‐independent acquisition strategies. Consequently, disease‐associated biomarker candidates often represent a mixture of altered corona proteins and intrinsic EV proteins (Chaemsaithong et al. 2025), which could complicate downstream interpretation and validations unless corona proteins are systematically annotated and filtered. Second, the protein corona can sterically mask EV surface proteins, thus limiting detection of surface biomarkers. Consistent with this, stripping the corona layer using a high‐ionic strength buffer improve detection of a substantial fraction of surface markers on plasma‐derived small EVs (15 out of 37) and THP‐1‐derived small EVs (9 out of 37) by multiplex immunoassay (Försönits et al. 2025). Together, these findings indicate the protein corona as a persistent challenge for EV biomarker discovery and liquid biopsy efforts. This unmet need can be approached by using Venn diagram‐based comparisons to define the logical relationship between the established EV protein corona datasets and user‐provided protein lists, such as those derived from EV proteomic analyses. Overlapping proteins are annotated as putative corona proteins, enabling identification of non‐corona EV surface and intraluminal proteins for subsequent analyses. Accessibility, transparency, reliability and reproducibility are central for bioinformatic analyses. Accordingly, a user‐friendly, web‐based platform incorporating experimentally validated protein corona reference datasets is essential to support standardised and reproducible investigations of EV protein corona across the EV research community, independent of computational expertise. Accordingly, a web‐based tool, EVennCorona, was developed to annotate EV protein corona using Venn diagram‐based comparisons (Figure 1A, B). The database contains pre‐defined sets of experimentally validated protein corona curated from studies employing strategies to identify or subtract corona proteins (Figure 1C). These include pulsing nascent EVs, generated from cell cultures under serum‐free conditions, to protein‐rich biofluids such as blood plasma (Tóth et al. 2021; Dietz et al. 2023), as well as striping protein corona using competitive ionic interactions (e.g., hypertonic salt solutions or cationic peptides) (Singh et al. 2023) or denaturing detergents (Liam‐Or et al. 2024). Proteins identified from synthetic nanoparticles and liposomes incubated in human plasma were also included as complementary references for plasma protein corona (Weber et al. 2018; Kari et al. 2020). Development and applications of EVennCorona for plasma extracellular vesicle (EV) protein corona annotation. (A) Workflow illustrating the development of the EVennCorona web‐based tool (scripts are available at github.com/schuti/EVennCorona). (B) Screenshot of the EVennCorona web interface (https://schuti.github.io/EVennCorona), demonstrating an analysis of a simulated dataset (IGHG1, ALB, C3, CD9, TSG101 and GAPDH) against the plasma protein corona reference dataset from diverse EV populations (All EV‐pC). (C) Overview of 10 plasma protein corona datasets from six independent studies. (D) Prioritisation of plasma EV biomarker candidates by filtering out putative protein corona. (E) Shared plasma protein corona components among EV populations, including stem cells, monocytes, epithelial cells, erythrocytes and platelets. Recent advances in artificial intelligence (AI) enable rapid translation of concepts into functional analytical tools through agent‐assisted coding. EVennCorona was developed using JavaScript generated with the Cursor AI code editor coupled to a ChatGPT‐5.2 agent, refined through iterative prompt optimisation, resulting in a first viable product (Figure 1A). The initial implementation supported accurate rendering of Venn diagrams for up to three datasets but failed for more complex configurations. To enable visualisation of four‐ and five‐set intersections, pre‐defined scalable vector graphics layouts with exact geometry and rotation were incorporated. EVennCorona now supports one to five datasets, with or without user's defined protein list. For reproducibility, reference protein corona datasets are standardised to gene symbols. Outputs include downloadable Venn diagrams and a tabulated shared and unique proteins, facilitating EV corona analysis, biomarker prioritisation and hypothesis generation. As a representative used case, our group recently reported 17 plasma EV proteins as biomarker candidates for pregnancies affected by foetal haemoglobin Bart's disease (Chaemsaithong et al. 2025), including placenta‐specific alkaline phosphatase (PLAP) detected by immunoassay and APOB, C1QA, C1R, DCD, FGA, FGB, FGG, HNRNPA2B1, HP, HRNR, HSPA8, IGHA2, IGKV4‐1, IGLL5, KRT6B and LPA identified by SWATH‐targeted proteomics. Several of these proteins are abundant plasma proteins and therefore potential constituents of the EV protein corona. To prioritise intrinsic EV biomarkers, the candidate list was annotated against curated plasma protein corona datasets derived from diverse EV populations (Tóth et al. 2021; Dietz et al. 2023; Singh et al. 2023; Liam‐Or et al. 2024), as well as from polystyrene nanoparticles (Weber et al. 2018) and liposomes (Kari et al. 2020). Only three out of 17 candidates, PLAP, HNRNPA2B1 and HSPA8, were classified as non‐corona EV proteins (Figure 1D), supporting their further development as EV liquid biopsy for haemoglobin Bart's disease in pregnant women at risk. Comparison of plasma protein corona across diverse EV populations can provide insights into cellular targeting and opportunities for corona bioengineering. EVennCorona was used to map the shared and unique corona proteins from EVs derived from stem cells (Liam‐Or et al. 2024), immune cells (Tóth et al. 2021), epithelial cells (Dietz et al. 2023), red blood cells (Singh et al. 2023) and platelets (Tóth et al. 2021). Surprisingly, no proteins were common to all five EV types (Figure 1E). Only complement C9 was shared among four EV types, and four proteins (PLG, IGHG4, IGLL5 and HPR) were shared among three. The majority of corona proteins were unique to each EV population. Despite methodological heterogeneity across the source studies, this result suggests that protein corona formation is a selective process, probably determined by EV surface composition and their cell of origin, rather than stochastic protein adsorption. This selectivity supports the functional relevance of the absorbed corona layer and represents an opportunity for corona bioengineering to tailor EV surface properties for specific therapeutic applications. Soluble plasma proteins, previously considered contaminants of EV preparation, may coexist with protein corona within the same isolates (Welsh et al. 2024). To avoid misannotation, EVennCorona should be applied only after rigorous EV characterisation following the MISEV2023 guidelines, demonstrating enrichment of common EV markers (e.g., CD9, CD63, CD81, TSG101, ALIX and HSP70) and depletion of abundant plasma proteins (i.e., albumin, immunoglobulins, apolipoproteins and fibrinogens) (Welsh et al. 2024). Quantitative proteomic comparison of plasma EV samples against matched plasma provides comprehensive EV marker and plasma protein profiles that fulfil EV quality control and enable simultaneous annotation of intrinsic EV proteins and corona‐associated proteins using EVennCorona. Looking forward, the definition of protein corona for EVs requires reconsideration. Unlike synthetic nanoparticles, where any surface‐bound proteins can readily be classified as corona, EVs possess native surface ligands and receptors inherited from their parent cells (Buzas 2022). For example, immunoglobulins are frequently identified as plasma protein corona across studies (Tóth et al. 2021; Dietz et al. 2023; Singh et al. 2023; Liam‐Or et al. 2024; Weber et al. 2018; Kari et al. 2020). The corona of B cell‐derived EVs may acquire pentameric IgM from plasma, but this EV type also displays monomeric IgM on the surface as transferred from the original cells (Gutknecht et al. 2023). Without careful distinction, IgM could be misannotated as corona. Similarly, EVs expressing Fc receptors can bind IgG either via high affinity ligand–receptor interaction or through weak protein–protein interactions mediated by the corona layer once EV exposure to blood. Although the concepts of hard and soft corona from nanoparticle studies (Kari et al. 2020) may be applicable, EV corona definitions must account for membrane complexity and spatiotemporal dynamics. A consensus definition will guide accurate annotation and interpretation of EV protein corona in this emerging field of EV biology. Author Contributions Somchai Chutipongtanate: conceptualisation, investigation, validation, methodology, software, data curation, formal analysis, resources, writing – review and editing, writing – original draft, visualisation. Funding This work had no funding support. Conflicts of Interest The author declares no conflicts of interest.